Recent studies have shown that VEGF serum concentration, placental mRNA levels, and cytotrophoblast expression of VEGF and their receptors in HELLP patients are significantly lower than the serum concentration of patients suffering from severe preeclampsia (PE) but higher than the level in nonpregnant women [20,21]. The gene discussed is VEGFA; the disease is preeclampsia.